The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story The need for clean water after Helene ...
Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...
The Medicine Foundry, which is expected to create 400 jobs, will be situated in the LEAP Research and Innovation District in ...
Indianapolis-based Eli Lilly’s supply of Mounjaro, which is used to treat Type 2 diabetes, and popular weight-loss drug ...
"God knows what volume they're actually selling. And who knows? You're just taking it," one expert told The Post.
The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making ...
DSM-Firmenich's new sunscreen ingredient bemotrizinol (PARSOL Shield) is under FDA review; if approved, it would be the first ...
Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, threatening to upend the many knockoffs that became popular when ...
Eli Lilly is pouring another $4.5 billion into expanding manufacturing and development as the drugmaker rakes in billions ...
Eli Lilly is on track to become the first trillion-dollar pharma company, fueled by FDA-approved weight loss drugs. With a ...
A new study published in the journal JAMA Network Open found that food left in the stomach or stool left in the bowel can ...